Prognostic Value of CD133 and SOX2 in Advanced Cancer

BACKGROUND: The prognostic value of CD133 and SOX2 expression in advanced cancer remains unclear. This study was first conducted to investigate the association between CD133 or SOX2 positivity and clinical outcomes for advanced cancer patients. METHODS: Hazard ratios (HRs) with 95% confidence interv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Oncol
Hlavní autoři: Han, Susu, Huang, Tao, Wu, Xing, Wang, Xiyu, Liu, Shanshan, Yang, Wei, Shi, Qi, Li, Hongjia, Hou, Fenggang
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332999/
https://ncbi.nlm.nih.gov/pubmed/30693028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3905817
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky